These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31649536)

  • 41. Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database.
    Roberto G; Piccinni C; D'Alessandro R; Poluzzi E
    Cephalalgia; 2014 Jan; 34(1):5-13. PubMed ID: 23921799
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System.
    Raschi E; Poluzzi E; Koci A; Antonazzo IC; Marchesini G; De Ponti F
    Nutr Metab Cardiovasc Dis; 2016 May; 26(5):380-6. PubMed ID: 27067162
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Does spontaneous adverse drug reactions' reporting differ between different reporters? A study in Toulouse Pharmacovigilance Centre.
    Nicol C; Moulis F; Bondon-Guitton E; Durrieu G; Montastruc JL; Bagheri H
    Therapie; 2019 Oct; 74(5):521-525. PubMed ID: 31029402
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analyses of Adverse Drug Reactions-Nationwide Active Surveillance Network: Canadian Pharmacogenomics Network for Drug Safety Database.
    Tanoshima R; Khan A; Biala AK; Trueman JN; Drögemöller BI; Wright GEB; Hasbullah JS; Groeneweg GSS; Ross CJD; Carleton BC;
    J Clin Pharmacol; 2019 Mar; 59(3):356-363. PubMed ID: 30452777
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
    Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
    Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recovery from vestibular ototoxicity.
    Black FO; Gianna-Poulin C; Pesznecker SC
    Otol Neurotol; 2001 Sep; 22(5):662-71. PubMed ID: 11568676
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SGLT-2 inhibitors and ketoacidosis: a disproportionality analysis in the World Health Organization's adverse drug reactions database.
    Ado Moumouni AN; Robin P; Hillaire-Buys D; Faillie JL
    Fundam Clin Pharmacol; 2018 Apr; 32(2):216-226. PubMed ID: 29144574
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cataracts and statins. A disproportionality analysis using data from VigiBase.
    Macías Saint-Gerons D; Bosco Cortez F; Jiménez López G; Castro JL; Tabarés-Seisdedos R
    Regul Toxicol Pharmacol; 2019 Dec; 109():104509. PubMed ID: 31669197
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adverse drug reaction reporting: how can drug consumption information add to analyses using spontaneous reports?
    Svendsen K; Halvorsen KH; Vorren S; Samdal H; Garcia B
    Eur J Clin Pharmacol; 2018 Apr; 74(4):497-504. PubMed ID: 29255992
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
    Tandon VR; Mahajan V; Khajuria V; Gillani Z
    Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ibuprofen-associated hypothermia in children: analysis of the Italian spontaneous reporting database.
    Donati M; Monaco L; Melis M; Sottosanti L; Biagi C; Vaccheri A; Motola D
    Eur J Clin Pharmacol; 2016 Oct; 72(10):1239-1243. PubMed ID: 27417946
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Texting-Based Reporting of Adverse Drug Reactions to Ensure Patient Safety: A Feasibility Study.
    Vergeire-Dalmacion G; Castillo-Carandang NT; Juban NR; Amarillo ML; Tagle MP; Baja ES
    JMIR Public Health Surveill; 2015; 1(2):e12. PubMed ID: 27227130
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The impact of a changed legislation on reporting of adverse drug reactions in Sweden, with focus on nurses' reporting.
    Karlsson SA; Jacobsson I; Boman MD; Hakkarainen KM; Lövborg H; Hägg S; Jönsson AK
    Eur J Clin Pharmacol; 2015 May; 71(5):631-6. PubMed ID: 25845655
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adverse drug reactions during hepatitis C treatment with direct-acting antivirals: The role of medication errors, their impact on treatment discontinuation and their preventability. New insights from the Campania Region (Italy) spontaneous reporting system.
    Sessa M; Bernardi FF; Vitale A; Schiavone B; Gritti G; Mascolo A; Bertini M; Scavone C; Sportiello L; Rossi F; Capuano A
    J Clin Pharm Ther; 2018 Dec; 43(6):867-876. PubMed ID: 30014479
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacovigilance in ophthalmology in Switzerland: an analysis of the most frequently reported ocular adverse drug reactions within the last 25 years.
    Karrer JE; Giovannoni L; Kullak-Ublick GA; Weiler S
    Swiss Med Wkly; 2019 Jun; 149():w20085. PubMed ID: 31256417
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spontaneous adverse drug reaction reporting by patients in Canada: a multi-method study-study protocol.
    Dweik RA; Yaya S; Stacey D; Kohen D
    Springerplus; 2016; 5():213. PubMed ID: 27026907
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cyclo-oxygenase selectivity and chemical groups of nonsteroidal anti-inflammatory drugs and the frequency of reporting hypersensitivity reactions: a case/noncase study in VigiBase.
    Bakhriansyah M; Meyboom RHB; Souverein PC; de Boer A; Klungel OH
    Fundam Clin Pharmacol; 2019 Oct; 33(5):589-600. PubMed ID: 30860620
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database.
    Raschi E; Piccinni C; Poluzzi E; Marchesini G; De Ponti F
    Acta Diabetol; 2013 Aug; 50(4):569-77. PubMed ID: 22008948
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001).
    Thiessard F; Roux E; Miremont-Salamé G; Fourrier-Réglat A; Haramburu F; Tubert-Bitter P; Bégaud B
    Drug Saf; 2005; 28(8):731-40. PubMed ID: 16048358
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of unknown ototoxic adverse drug reactions: an electronic healthcare record-based longitudinal nationwide cohort analysis.
    Lee S; Cha J; Kim JY; Son GM; Kim DK
    Sci Rep; 2021 Jul; 11(1):14045. PubMed ID: 34234249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.